Global Injectable Drug Delivery Devices Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Injectable Drug Delivery Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Injectable Drug Delivery Devices Market Size and Projected Growth Rate?
The market size for injectable drug delivery devices has seen swift expansion in the past few years. The market is projected to increase from $49.59 billion in 2024 to $54.67 billion in 2025, displaying a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this historical growth include a surge in the elderly population, expansion of healthcare facilities, augmented health care spending, growth in the field of biologics, and increased awareness about self-administration.

A significant expansion is anticipated for the injectable drug delivery devices market in the forthcoming years, with expectations of reaching a market size of $75.28 billion in 2029 and an estimated compound annual growth rate (CAGR) of 8.3%. This projected growth is primarily due to factors such as the rising prevalence of chronic illnesses, increasing demand for injectable medications, the sudden onset of severe infections, and a large array of drugs and vaccines currently in various clinical trial stages. Furthermore, key trends anticipated to influence the market during this forecast period include the emphasis on the creation of microneedle-based drug delivery systems, investment in the research and development for self-injectable devices, the manufacturing focus on wearable and needle-free injection devices, product line expansion into prefilled syringes, enhancement of their devices' digital technology, and the manufacturing focus on innovative devices and auto-injectors.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2835

What Are the Major Segments in the Injectable Drug Delivery Devices Market?
The injectable drug delivery devices market covered in this report is segmented -

1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

What Are The Driving Injectable Drug Delivery Devices Market Evolution?
The rising inclination towards self-administered injection devices is propelling the market for injectable drug delivery devices. These devices, which include needle-free, auto-injector, pen and wearable injectors, allow patients to conveniently administer their own medication at home. The devices offer not only ease of use, but also high precision in drug deliverance. These devices' popularity has significantly increased recently due to their innovative designs. The BD Physioject, a disposable auto-injector produced by Becton, Dickinson, and Company, has been clinically proven to be reliable, cost-effective, and explicitly designed for patients with chronic diseases like rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis to administer their own medication. Further market participants in self-injection include AbbVie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., among others. Increased awareness about self-administration and the benefits of self-injectable injections have driven demand for these devices, fuelling growth in the injectable drug delivery devices market in the forecasted period.

Which Firms Dominate The Injectable Drug Delivery Devices Market Segments?
Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

What Trends Are Driving Growth in The Injectable Drug Delivery Devices Market?
Companies in the injectable drug delivery device sector are intensifying their efforts to manufacture auto-injectors. These devices, which are fully automated, highly specialized, and reusable, can be used by patients for numerous injections. They allow patients to regulate the delivery rate of the dose, thus reducing pain or discomfort during the injection process. The devices also have the capability to adjust the speed and depth of the automatic injection. An example of this is the LISA, a reusable auto-injector from Unilife corporation, which boasts various configurable features such as Bluetooth LE, Wi-Fi or 3G connectivity, and a pre-injection drug warming feature for specific therapies. The injectable drug delivery technology market is predicted to witness considerable growth in the upcoming years, thanks to various technical innovations and the introduction of new products aimed at improving the simplicity and convenience of parenteral therapeutic administration.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Which Is The Largest Region In The Injectable Drug Delivery Devices Market?
North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Injectable Drug Delivery Devices Market?
2. What is the CAGR expected in the Injectable Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Injectable Drug Delivery Devices Industry?
4. Which Region Is Leading the Injectable Drug Delivery Devices Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.